2026 - Passed
Tennessee H.B. 1741/S.B. 1790
  • Requires a health insurer that offers a policy covering an inmate incarcerated in Tennessee to adopt or amend their preferred drug list so that any FDA-approved non-opioid medication is not disadvantaged or discouraged in coverage compared with an opioid for the treatment or management of pain.
State Regulated Commercial Parity
Read House BillRead Senate Bill
2025 - Introduced
Utah S.B. 331
  • Prohibits Medicaid and health insurers from imposing more restrictive or extensive prescription drug utilization management practices for a non-opioid drug than the least restrictive or extensive practice applicable to any opioid.
  • Requires that if Utah Department of Health and Human Services funding is available, pamphlets about opiates should include information about non-opioid drug alternatives.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2026 - Introduced
Virginia H.B. 516
  • Prohibits commercial health insurers from imposing limitations or utilization controls on coverage of a covered FDA-approved non-opioid drug that are more restrictive or less favorable to the enrollee relative to the coverage of an opioid drug for the treatment or management of pain.
State Regulated Commercial Parity
Read House Bill
2025 - Introduced
Virginia H.B.1765
  • Prohibits health insurers from imposing cost-sharing, prior authorization, step therapy, or other coverage limitations on a covered FDA-approved non-opioid drug.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Introduced
Washington H.B.1034
  • Prohibits health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
West Virginia H.B. 3070/S.B. 628
  • Prohibits West Virginia's Medicaid and commercial health insurance formularies or preferred drug lists from disadvantaging or discouraging a non-opioid drug with respect to coverage of an opioid drug, including through more restrictive coverage criteria, utilization management, or cost sharing.
  • Requires the West Virginia Bureau of Public Health develop educational materials about non-opioid alternatives for the treatment of acute pain.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill
2025 - Introduced
Wisconsin A.B. 499/S.B. 492
  • Requires health insurers to provide coverage for at least two FDA-approved non-opioid prescription medication treatment options and three alternative nonpharmacological treatment modalities.
  • Prohibits utilization controls that are more restrictive or extensive than the least restrictive or extensive utilization controls for opioids.
  • Requires health insurers to provide information about the pain management access plan to enrollees and health care providers and to make the plan available on its website.
State Regulated Commercial Parity
Read House BillRead Senate Bill